Photo of Mark R. Stone, MD

Mark R. Stone, MD

Accepting New Patients
1000 North Providence Drive, Suite 310
Newberg, OR 97132
2043.1 miles away
Medical Groups & Affiliations
Providence Medical Group - Oregon
Speaks: English
map

Providence Cancer Institute - Newberg

1000 North Providence Drive, Suite 310, Newberg, OR 97132

Are you covered?

Check to see if your insurance is covered by this provider.

About Mark R. Stone

Dr. Mark Stone is a general hematologist and oncologist. He has extensive experience providing care for patients with a wide variety of cancer types and blood disorders. In his practice, Dr. Stone understands that communication with his patients is a vital aspect of his role as a physician. He is motivated to help his patients thrive.

Residency

University of California San Diego Medical Center
1999

Fellowship

University of California San Diego
2003

Medical School

University of California Irvine
1996

Board Certifications
  • American Board of Internal Medicine, Medical Oncology
  • American Board of Internal Medicine, Hematology
Providence Cancer Institute - Newberg
1000 North Providence Drive, Suite 310
Newberg, OR 97132

Medical Groups & Affiliations
Providence Medical Group - Oregon

Affiliated Locations
Providence Newberg Medical Center

Clinical Interests

  • Aids Related Malignancies
  • Anal Cancer
  • Anorectal Cancer
  • Atypical Ductal Hyperplasia
  • Bladder Cancer
  • Breast Cancer
  • Breast Lump
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Genomics
  • Cancer Pain
  • Cancer Rehabilitation
  • Cancer Related Anxiety Disorder
  • Cancer Related Bereavement Disorder
  • Cancer Related Depression
  • Cancer Related Fatigue
  • Cancer Related Psychiatric Disorder
  • Cancer Related Stress Disorder
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoid Tumor
  • Carcinoma In Situ Of Breast
  • Carcinoma Of Unknown Primary
  • Chemoradiation
  • Chest Wall Tumors
  • Clinical Trials
  • Colon Cancer
  • Colorectal Cancer
  • Crizotinib
  • Ductal Carcinoma In Situ (Dcis)
  • Egfr Mutation
  • Egfr Translocation
  • Endocrine Complications Of Cancer Therapy
  • Erlotinib
  • Esophageal Cancer
  • Gastroesophageal Junction Cancer
  • Head And Neck Cancer
  • Hematologic Malignancies
  • Hemochromatosis
  • Hypopharyngeal Cancer
  • Laryngeal Cancer
  • Leukocytosis
  • Leukopenia
  • Lobular Carcinoma In Situ (Lcis)
  • Lung Cancer
  • Lung Mass
  • Lung Metastasis
  • Lymphedema Therapy
  • Lymphoma
  • Male Breast Cancer
  • Malignant Neoplasm Of Esophagus
  • Mediastinal Mass
  • Melanoma
  • Mesothelioma
  • Metastatic Breast Cancer
  • Metastatic Liver Cancer
  • Metastatic Tumors To The Lungs
  • Multiple Myeloma
  • Neoplasm Of Salivary Gland
  • Non Hodgkin Lymphoma
  • Non Small Cell Lung Cancer
  • Oral Complications Of Cancer
  • Oral Lesions
  • Ovarian Cancer
  • Pancreas Cancer
  • Plasma Cell Dyscrasia
  • Polycythemia
  • Primary Myelofibrosis
  • Prostate Cancer
  • Pulmonary Metastases
  • Recurrent Colorectal Cancer
  • Retroperitoneal Mass
  • Sickle Cell Disease
  • Side Effects Of Cancer Treatment
  • Small Cell Lung Cancer
  • Squamous Cell Carcinoma Of The Head And Neck
  • Squamous Cell Carcinoma Of The Tongue
  • Stomach Cancer
  • Supratentorial Primitive Neuroectodermal Tumor
  • Targeted Molecular Therapy
  • Thoracic Cancer
  • Thoracic Malignancy
  • Thrombocytopenia
  • Tracheal Cancer
  • Tracheal Mass
  • Unknown Primary Cancer
  • Virtual Care